Realcan Pharmaceutical Group Co., Ltd. (002589.SZ)
CNY 2.81
(0.72%)
CNY 2.81
(0.72%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -126.63 Million CNY | -288.7% |
| 2022 | 67.11 Million CNY | -94.84% |
| 2021 | 1.3 Billion CNY | -23.7% |
| 2020 | 1.7 Billion CNY | -32.85% |
| 2019 | 2.53 Billion CNY | -6.07% |
| 2018 | 2.7 Billion CNY | 49.23% |
| 2017 | 1.81 Billion CNY | 110.17% |
| 2016 | 861.34 Million CNY | 178.81% |
| 2015 | 308.94 Million CNY | 31.04% |
| 2014 | 235.76 Million CNY | 20.72% |
| 2013 | 195.3 Million CNY | 28.54% |
| 2012 | 151.94 Million CNY | 33.81% |
| 2011 | 113.55 Million CNY | 33.37% |
| 2010 | 85.14 Million CNY | 35.38% |
| 2009 | 62.88 Million CNY | 58.64% |
| 2008 | 39.64 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 46.84 Million CNY | 195.47% |
| 2024 Q1 | 26.38 Million CNY | 114.84% |
| 2024 Q2 | 15.85 Million CNY | -39.91% |
| 2023 Q3 | -13.72 Million CNY | -143.1% |
| 2023 Q4 | -177.73 Million CNY | -1194.74% |
| 2023 FY | -126.63 Million CNY | -288.7% |
| 2023 Q1 | 32.97 Million CNY | 101.72% |
| 2023 Q2 | 31.85 Million CNY | -3.41% |
| 2022 Q3 | 229.25 Million CNY | 182.53% |
| 2022 Q4 | -1.91 Billion CNY | -934.29% |
| 2022 FY | 67.11 Million CNY | -94.84% |
| 2022 Q1 | 201.82 Million CNY | 483.9% |
| 2022 Q2 | 81.14 Million CNY | -59.8% |
| 2021 FY | 1.3 Billion CNY | -23.7% |
| 2021 Q2 | 156.38 Million CNY | -35.98% |
| 2021 Q3 | 151 Million CNY | -3.44% |
| 2021 Q4 | -52.57 Million CNY | -134.82% |
| 2021 Q1 | 244.25 Million CNY | 399.12% |
| 2020 Q4 | 48.93 Million CNY | -86.22% |
| 2020 Q3 | 355.17 Million CNY | 0.64% |
| 2020 FY | 1.7 Billion CNY | -32.85% |
| 2020 Q1 | 197.44 Million CNY | 116.81% |
| 2020 Q2 | 352.91 Million CNY | 78.74% |
| 2019 Q2 | 470.86 Million CNY | 16.9% |
| 2019 Q3 | 430.47 Million CNY | -8.58% |
| 2019 FY | 2.53 Billion CNY | -6.07% |
| 2019 Q1 | 402.8 Million CNY | 26.77% |
| 2019 Q4 | -1.17 Billion CNY | -372.82% |
| 2018 Q3 | 525.71 Million CNY | -18.27% |
| 2018 FY | 2.7 Billion CNY | 49.23% |
| 2018 Q4 | 317.74 Million CNY | -39.56% |
| 2018 Q2 | 643.22 Million CNY | 31.97% |
| 2018 Q1 | 487.42 Million CNY | -17.96% |
| 2017 FY | 1.81 Billion CNY | 110.17% |
| 2017 Q3 | 381.67 Million CNY | 8.44% |
| 2017 Q4 | 594.12 Million CNY | 55.66% |
| 2017 Q2 | 351.95 Million CNY | -27.06% |
| 2017 Q1 | 482.5 Million CNY | 51.88% |
| 2016 FY | 861.34 Million CNY | 178.81% |
| 2016 Q2 | 173.9 Million CNY | 43.06% |
| 2016 Q3 | 248.18 Million CNY | 42.71% |
| 2016 Q4 | 317.69 Million CNY | 28.01% |
| 2016 Q1 | 121.56 Million CNY | 28.16% |
| 2015 Q2 | 69.87 Million CNY | 12.31% |
| 2015 Q3 | 82 Million CNY | 17.36% |
| 2015 Q4 | 94.84 Million CNY | 15.66% |
| 2015 FY | 308.94 Million CNY | 31.04% |
| 2015 Q1 | 62.21 Million CNY | 4.56% |
| 2014 Q3 | 69.31 Million CNY | 31.24% |
| 2014 Q2 | 52.81 Million CNY | -2.45% |
| 2014 Q1 | 54.14 Million CNY | -10.51% |
| 2014 FY | 235.76 Million CNY | 20.72% |
| 2014 Q4 | 59.49 Million CNY | -14.16% |
| 2013 Q2 | 40.99 Million CNY | -0.04% |
| 2013 FY | 195.3 Million CNY | 28.54% |
| 2013 Q4 | 60.5 Million CNY | 14.59% |
| 2013 Q3 | 52.79 Million CNY | 28.8% |
| 2013 Q1 | 41.01 Million CNY | -9.46% |
| 2012 Q4 | 45.29 Million CNY | 4.28% |
| 2012 Q3 | 43.43 Million CNY | 38.75% |
| 2012 Q2 | 31.3 Million CNY | -1.87% |
| 2012 Q1 | 31.9 Million CNY | -19.78% |
| 2012 FY | 151.94 Million CNY | 33.81% |
| 2011 FY | 113.55 Million CNY | 33.37% |
| 2011 Q3 | 29.2 Million CNY | 18.68% |
| 2011 Q2 | 24.6 Million CNY | 23.18% |
| 2011 Q1 | 19.97 Million CNY | -28.05% |
| 2011 Q4 | 39.76 Million CNY | 36.18% |
| 2010 Q2 | 20.71 Million CNY | 36.53% |
| 2010 Q4 | 27.76 Million CNY | 29.18% |
| 2010 FY | 85.14 Million CNY | 35.38% |
| 2010 Q1 | 15.17 Million CNY | 0.0% |
| 2010 Q3 | 21.49 Million CNY | 3.77% |
| 2009 FY | 62.88 Million CNY | 58.64% |
| 2008 FY | 39.64 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| China National Accord Medicines Corporation Ltd. | 2.34 Billion CNY | 105.395% |
| Shenzhen Glory Medical Co.,Ltd. | -121.22 Million CNY | -4.464% |